{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:37:21Z","timestamp":1780720641596,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1378\/chest.130.6.1823","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T13:31:20Z","timestamp":1166016680000},"page":"1823-1827","source":"Crossref","is-referenced-by-count":62,"title":["Anticoagulant and Antiplatelet Therapy Use in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"130","author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Karpha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.130.6.1823_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/hrt.2005.071555","article-title":"Antithrombotic treatment in atrial fibrillation","volume":"92","author":"Lip","year":"2006","journal-title":"Heart"},{"issue":"suppl 5","key":"10.1378\/chest.130.6.1823_bib2","first-page":"v1","article-title":"JBS 2: Joint British Societies\u2019 guidelines on prevention of cardiovascular disease in clinical practice Prepared by: British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association","volume":"91","year":"2005","journal-title":"Heart"},{"key":"10.1378\/chest.130.6.1823_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","article-title":"Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"23","author":"Bertrand","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.130.6.1823_bib4","first-page":"804","article-title":"Task Force for Percutaneous Coronary Intervention of the European Society of Cardiology. Guidelines for percutaneous coronary interventions","volume":"26","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.130.6.1823_bib5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.130.6.1823_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2005.09.012","article-title":"Anticoagulation plus aspirin following acute myocardial infarction: yes or no \u2026 and if the latter, why not?","volume":"118","author":"Lip","year":"2006","journal-title":"Thromb Res"},{"key":"10.1378\/chest.130.6.1823_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.130.6.1823_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-8703(03)00325-9","volume":"146","author":"Halperin","year":"2003","journal-title":"Am Heart J"},{"key":"10.1378\/chest.130.6.1823_bib9","article-title":"National Collaborating Centre for Chronic Conditions","year":"2006"},{"key":"10.1378\/chest.130.6.1823_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ahj.2003.06.004","article-title":"Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation","volume":"147","author":"Orford","year":"2004","journal-title":"Am Heart J"},{"key":"10.1378\/chest.130.6.1823_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.1.6174.1332","article-title":"Accuracy of hospital activity notifications for infectious diseases","volume":"1","author":"George","year":"1979","journal-title":"Br Med J"},{"key":"10.1378\/chest.130.6.1823_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1368-5031.2006.00824.x","article-title":"A review of the management of patients after percutaneous coronary intervention","volume":"60","author":"Wong","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1378\/chest.130.6.1823_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-2006-941730","article-title":"Dual antithrombotic therapy after implantation of coronary stents","volume":"131","author":"Schneider","year":"2006","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1378\/chest.130.6.1823_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(03)14287-0","article-title":"Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomized controlled trial","volume":"362","author":"Wallentin","year":"2003","journal-title":"Lancet"},{"key":"10.1378\/chest.130.6.1823_bib15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.316.7141.1337","article-title":"ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomized comparison of IV streptokinase, oral aspirin, both, or neither; The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"316","author":"Baigent","year":"1998","journal-title":"BMJ"},{"key":"10.1378\/chest.130.6.1823_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"The Clopidogrel in Unstable Angina To Prevent Recurrent Events (CURE) Trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.130.6.1823_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1378\/chest.130.6.1823_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ehj.2004.03.006","article-title":"Long-term clopidogrel therapy after percutaneous coronary intervention in PCI-CURE and CREDO: the \u201cemperor\u2019s new clothes\u201d revisited","volume":"25","author":"Eriksson","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.130.6.1823_bib19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin vs aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.130.6.1823_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel vs aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1378\/chest.130.6.1823_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/eurheartj\/ehi485","article-title":"Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients","volume":"27","author":"Andreotti","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.130.6.1823_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomized controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1378\/chest.130.6.1823_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-143-4-200508160-00005","article-title":"Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit","volume":"143","author":"Rothberg","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.130.6.1823_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinte.165.7.784","article-title":"Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction","volume":"165","author":"Buresly","year":"2005","journal-title":"Arch Intern Med."},{"key":"10.1378\/chest.130.6.1823_bib25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.130.5.1296","article-title":"Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema","volume":"130","author":"Kakar","year":"2006","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215509082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215509082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:58:19Z","timestamp":1547139499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215509082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0012369215509082"],"URL":"https:\/\/doi.org\/10.1378\/chest.130.6.1823","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}